Bloomberg Law
June 21, 2024, 5:11 PM UTC

Altria’s Menthol E-Cigs Get FDA Nod as Menthol Debate Continues

Sophia Vahanvaty
Tiffany Kary
Tiffany Kary
Bloomberg News

The US Food and Drug Administration said Friday it’s allowing tobacco giant Altria Group Inc. to market four different menthol-flavored e-cigarettes, just two months after the Biden administration <-bsp-bb-link state="{"bbDocId":"SCKDI6T0AFB5","_id":"00000190-3bc9-d497-a7fb-ffcd78d90001","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">controversially delayed making a decision about banning menthol cigarette sales.

The products, marketed under Altria’s NJOY brand, are the first e-cigarettes to be <-bsp-bb-link state="{"bbDocId":"SFFQK2MB2SJM","_id":"00000190-3bc9-d497-a7fb-ffcd78d90002","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">approved that aren’t tobacco flavored. Before Friday, questions had been looming around whether the FDA would ever approve an e-cigarette with a flavor besides tobacco. The move will also help Atria diversify its business.

“The FDA’s authorization of four of Altria’s NJOY brand menthol-flavored e-cigarettes can aid the company’s ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.